QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)

BioForce Nanosciences (BFNH) SEC Filings & 10K Form

$1.75
+0.04 (+2.34%)
(As of 04/17/2024 ET)

Recent BioForce Nanosciences SEC Filings

DateFilerForm TypeView
04/01/2024
2:35 PM
BioForce Nanosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/03/2023
8:44 AM
BioForce Nanosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2023
3:16 PM
BioForce Nanosciences (Issuer)
Ferguson Merle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
2:11 PM
BioForce Nanosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2023
2:01 PM
BioForce Nanosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (OTCMKTS:BFNH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners